Call Us: 888-488-5750

Rebate Audits Are On the Rise—Is Your Program Ready?

As healthcare organizations look to rebate programs to offset tightening margins, audit readiness is becoming a strategic necessity.

Increased scrutiny from manufacturers and evolving requirements around documentation, PHI use, and clinical coding are shifting rebate submissions from “nice-to-have” to regulated deliverables.

Common Audit Pitfalls

  • Incomplete or misaligned NDC/HCPCS mapping
  • Lack of sourcing documentation, especially for physician-administered drugs
  • Submitting PHI when not necessary—or failing to submit minimum required elements
  • Using a one-size-fits-all model across different rebate programs

What an Audit-Ready Program Looks Like

  • Traceable, clean claims with supporting encounter-level data
  • Documentation protocols tailored to manufacturer expectations
  • Policy alignment that ensures only eligible, verified claims are submitted
  • De-identification practices that respect HIPAA minimum necessary standards

How VativoRx Supports Clients

  • We design rebate programs that balance:
  • Compliant claim documentation
  • Automation that scales
  • Minimal burden on provider or health plan teams

If you’re unsure whether your program can stand up to audit scrutiny, we can help you get there.

Contact us to schedule a rebate review or learn how to strengthen your audit trail.

Are Provider-Led Health Plans Leaving Rebate Dollars Behind?

As hospitals and health systems evolve into risk-bearing organizations, many are launching their own health plans or taking on delegated risk through Medicare Advantage, ACOs, and MSOs. This shift creates new opportunities for financial sustainability, but also introduces new challenges.

Read More »

A New 340B Pilot Signals a Shift in Strategic Rebate Management

On August 1, 2025, the Centers for Medicare & Medicaid Services (CMS) announced the application process for the 340B Rebate Model Pilot Program, a move that may redefine how providers access cost relief under the 340B program. Instead of traditional point-of-sale discounts, this pilot will allow for rebates after purchase for covered outpatient drugs reimbursed under Medicaid.

Read More »